A recent controversy has sparked an important conversation about the ethics of weight-loss advertising, especially when it targets new mothers. The Advertising Standards Authority (ASA) has taken a stand against harmful gender stereotypes and irresponsible marketing tactics.
The ASA banned an advert by MedExpress, which promoted weight-loss injections specifically for new moms. This ad, along with two others by SkinnyJab and CheqUp, was deemed exploitative and irresponsible, playing on insecurities around body image. All three companies have since removed the ads.
Here's where it gets controversial: the ASA highlighted the illegal practice of advertising prescription-only weight loss drugs to the general public. They emphasized that the 'scale of the problem' is particularly acute now, as people feel extra pressure to shed pounds as part of their New Year resolutions.
MedExpress's Instagram video featured a woman taking a selfie, expressing regret for not knowing sooner about their 'medicated weight loss treatment.' The ASA pointed out that this medication carries safety warnings for breastfeeding individuals, and the ad perpetuated harmful body image stereotypes.
MedExpress responded by strengthening their internal processes and enhancing advertising governance across all their services. This incident underscores the need for responsible advertising, especially in the sensitive realm of health and wellness.
But here's the part most people miss: the stigma associated with body size. CheqUp's Facebook ad, featuring a woman in the mirror, hinted at this stigma with the quote, 'I don't want to be skinny, I just don't want to be the biggest person in the room.'
The ASA received complaints about this ad, arguing that it emphasized physical appearance over health. CheqUp defended their ad, stating that the model wanted to reach a healthy weight, but the ASA disagreed, suggesting that the model may not have been unhealthily overweight to begin with.
CheqUp, which sells both prescription and over-the-counter weight-loss jabs, claims to have a three-minute online consultation with a healthcare professional to assess suitability. However, the ASA's decision sends a clear message about the boundaries of ethical advertising.
Weight-loss jabs, originally developed to help diabetic patients, have gained popularity for cosmetic purposes. Celebrities like Adele, Rebel Wilson, Sharon Osbourne, and Elon Musk have openly discussed their rapid weight loss using these jabs, further fueling their popularity.
SkinnyJab's video, featuring their founder discussing weight loss injections, was deemed an advert, not an educational resource. The ASA's ruling means SkinnyJab cannot promote prescription-only medicines to the public, for example, by using the term 'SkinnyJab' in marketing.
SkinnyJab has since removed the advert and is reviewing their branding and communications. This incident serves as a reminder of the fine line between innovative marketing and exploitative practices.
So, what are your thoughts on this controversial topic? Do you think these ads crossed an ethical line, or is this a necessary step to address the growing weight-loss jab market? Share your opinions in the comments below!
